300 Participants Needed

EVAR vs ESAR for Abdominal Aortic Aneurysm

(HERCULES Trial)

Recruiting at 26 trial locations
SH
Dv
Overseen ByDaphne van der Veen, MSc
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Rijnstate Hospital
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial compares two methods of repairing abdominal aortic aneurysms in patients with wide aortic necks. One method uses a stent graft alone, while the other adds extra anchors to secure the graft. The goal is to see which method works better for these patients.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

Is the use of the Heli-FX EndoAnchor System and Endurant stent graft safe for treating abdominal aortic aneurysms?

The Heli-FX EndoAnchor System and Endurant stent graft have been shown to be safe for treating abdominal aortic aneurysms, including challenging cases with short necks, over a period of up to five years.12345

How is the ESAR treatment for abdominal aortic aneurysm different from other treatments?

The ESAR treatment is unique because it uses the Heli-FX EndoAnchor system to secure the stent graft, which helps prevent complications like leaks and migration, especially in patients with challenging aortic anatomies such as short necks. This approach enhances the stability and effectiveness of the endovascular repair compared to traditional methods.23456

What data supports the effectiveness of this treatment for abdominal aortic aneurysm?

Research shows that using the Heli-FX EndoAnchor system with the Endurant stent graft is effective and safe for treating abdominal aortic aneurysms, especially in challenging cases with short necks, over a period of five years.12345

Who Is on the Research Team?

MR

MMPJ Reijnen, Prof. Dr.

Principal Investigator

Rijnstate, Arnhem, the Netherlands

KD

K. Donas, Prof. Dr.

Principal Investigator

Asklepios Clinic Langen, Langen, Germany

Are You a Good Fit for This Trial?

This trial is for adults with abdominal aortic aneurysms that have a neck diameter of 28-32mm and are at least 10mm long. Candidates must need elective repair, fit the device guidelines, and not have had recent severe cardiovascular events or other conditions that could affect results or increase risks.

Inclusion Criteria

Provided written informed consent
I am choosing to have surgery that is not urgent.
Your neck is at least 10mm long.
See 3 more

Exclusion Criteria

The doctor thinks the patient may live for less than 2 years.
You are planning to use a specific medical device called AUI main body device.
My kidney function is low, with an eGFR below 30.
See 12 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants undergo the index procedure using either the Endurant II/IIs stent graft system alone or in conjunction with Heli-FX EndoAnchors

1 month
1 visit (in-person)

Follow-up

Participants are monitored for safety and effectiveness with assessments at 1 month and annually for up to 5 years post-index procedure

5 years
Annual visits (in-person)

What Are the Treatments Tested in This Trial?

Interventions

  • endosuture aneurysm repair (ESAR) using Heli-FX EndoAnchor system
  • endovascular aneurysm repair (EVAR) using the Endurant II/IIs stent graft system
  • endovascular sealing aneurysm repair (ESAR) using Heli-FX EndoAnchor system
Trial Overview The HERCULES trial compares two procedures for repairing infrarenal abdominal aortic aneurysms: EVAR using Endurant II/IIs stent grafts versus ESAR with Heli-FX EndoAnchor system. It's randomized, meaning patients are put into groups by chance to test which method works better.
How Is the Trial Designed?
2Treatment groups
Active Control
Group I: Standard endovascular aneurysm repair (EVAR) using the Endurant II/IIs stent graft systemActive Control1 Intervention
Group II: Endosuture aneurysm repair (ESAR) with the Endurant II/IIs in conjunction with EndoanchorsActive Control1 Intervention

endosuture aneurysm repair (ESAR) using Heli-FX EndoAnchor system is already approved in United States, European Union for the following indications:

🇺🇸
Approved in United States as Heli-FX EndoAnchor System for:
🇪🇺
Approved in European Union as Heli-FX EndoAnchor System for:

Find a Clinic Near You

Who Is Running the Clinical Trial?

Rijnstate Hospital

Lead Sponsor

Trials
195
Recruited
77,700+

Medtronic

Industry Sponsor

Trials
627
Recruited
767,000+
Geoff Martha profile image

Geoff Martha

Medtronic

Chief Executive Officer since 2020

Finance degree from Penn State University

Dr. Richard Kuntz profile image

Dr. Richard Kuntz

Medtronic

Chief Medical Officer since 2023

MD, MSc

Published Research Related to This Trial

In a study of 221 patients undergoing EndoSutured-aneurysm-repair (ESAR) with adjunct Heli-FX EndoAnchors, the procedure achieved a high technical success rate of 96.8% and a freedom from type Ia endoleaks of 94% at two years, indicating its efficacy in preventing complications during endovascular aneurysm repair.
The use of EndoAnchors showed positive trends in sac size reduction, with 92.2% of patients experiencing stable or regressed sac sizes after at least six months of follow-up, suggesting that this technique may be particularly beneficial for patients with challenging anatomical conditions.
Endovascular aortic repair with EndoAnchors demonstrate good mid-term outcomes in physician-initiated multicenter analysis-The PERU registry.Reyes Valdivia, A., Chaudhuri, A., Milner, R., et al.[2022]
In a study of 90 patients with ruptured abdominal aortic aneurysms (RAAAs), it was found that nearly 40% were initially unsuitable for endovascular aneurysm repair (EVAR) due to neck length issues, specifically necks shorter than 10 mm.
The use of Heli-FX EndoAnchors could significantly expand the eligibility for EVAR from 38.9% to 56.7% without correcting iliac deficiencies, and up to 75.6% if iliac issues are addressed, indicating a substantial potential benefit for RAAA patients.
Expanded Suitability of Ruptured Abdominal Aortic Aneurysms for Total Endovascular Repair Using the Endurant Endograft and Heli-FX EndoAnchors.Reyes Valdivia, A., Álvarez Marcos, F., Duque Santos, Á., et al.[2020]
In a study of 70 patients with short-neck abdominal aortic aneurysms (AAA), the Endurant II/IIs endograft combined with Heli-FX EndoAnchors achieved a high procedural success rate of 97.1% and a technical success rate of 88.6%.
The treatment demonstrated a low incidence of type IA endoleaks, with most resolving spontaneously, and no patients experienced serious complications like stent migration or aneurysm rupture within 12 months, indicating that this method is both safe and effective for challenging AAA anatomies.
Endosuture aneurysm repair in patients treated with Endurant II/IIs in conjunction with Heli-FX EndoAnchor implants for short-neck abdominal aortic aneurysm.Arko, FR., Stanley, GA., Pearce, BJ., et al.[2020]

Citations

Endovascular aortic repair with EndoAnchors demonstrate good mid-term outcomes in physician-initiated multicenter analysis-The PERU registry. [2022]
Expanded Suitability of Ruptured Abdominal Aortic Aneurysms for Total Endovascular Repair Using the Endurant Endograft and Heli-FX EndoAnchors. [2020]
Endosuture aneurysm repair in patients treated with Endurant II/IIs in conjunction with Heli-FX EndoAnchor implants for short-neck abdominal aortic aneurysm. [2020]
Five-year outcomes of endosuture aneurysm repair in patients with short neck abdominal aortic aneurysm from the ANCHOR registry. [2023]
Ruptured juxtarenal abdominal aortic aneurysm managed with endosuture aneurysm repair. [2022]
EndoSuture aneurysm repair versus fenestrated aneurysm repair in patients with short neck abdominal aortic aneurysm. [2023]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security